MicroRNAs (miRNAs) are short 20-22 nucleotide RNA molecules that act as negative regulators of gene expression via translational repression: they have been shown to play a role in development, proliferation, stress response, and apoptosis. The transcriptional regulator LRF (Leukemia/lymphoma Related Factor) has been shown to prevent p19ARF transcription and consequently to inhibit senescence in mouse embryonic fibroblasts (MEF). Here we report, for the first time, that LRF is post-transcriptionally regulated by miR-20a. Using a gene reporter assay, direct interaction of miR-20a with the LRF 39UTR is demonstrated. To validate the interaction miR-20a/39UTR LRF miR-20a was over-expressed, either by transient transfection or retroviral infection, in wild type mouse embryo fibroblasts and in LRF-null MEF derived from LRF knock-out mice. We observed LRF decrease, p19ARF increase, inhibition of cell proliferation and induction of senescence. The comparison of miR-20a activity in wt and LRF-null MEF indicates that LRF is the main mediator of the miR-20a-induced senescence and that other targets are cooperating. As LRF down-regulation/p19ARF induction is always accompanied by E2F1 down-regulation and increase of p16, we propose that all these events act in synergy to accomplish miR-20a-induced senescence in MEF. Senescence has been recently revaluated as a tumor suppressor mechanism, alternative to apoptosis; from this point of view the discovery of new physiological ''senescence inducer'' appears to be promising as this molecule could be used as anticancer drug.
Introduction
Pok proteins are a group of bifunctional proteins with potential oncogenic properties. They consist of an N terminal Poz domain and a C terminal kruppel-type (C2H2) zinc finger domain. The Cterminal zinc finger mediates specific DNA recognition and binding, while the amino-terminal POZ domain recruits histone deacetylase repressing transcription [1] . The oncogenic members of the Pok family include PLZF (Promyelocytic Leukemia Zinc Finger), whose t (11:17) translocation is at the basis of acute promyelocytic leukaemia, [2, 3] and BCL-6 (B cell Lymphoma 6), which is deregulated in many types of lymphoma [4] . Another member of the family is LRF (Leukemia/lymphoma Related Factor) encoded by the zbtb7a gene and localized on chromosome 19p13.3 which is a hot spot for chromosomal translocations in human tumors. This protein, already known to have pleiotropic functions during embryogenesis [5, 6, 7] , has recently been shown to act as an oncogene. When LRF is over-expressed in B and T lymphoid lineages (lckEm-LRF), mice develop aggressive lymphomas that cause death between 9 and 40 weeks of age [8] . Like the other members of the family, LRF is a transcriptional repressor and p19ARF has recently been found to be a specific target in MEF [9] . p19ARF oncosuppressor is known as a key mediator of cell senescence. It mainly acts by inhibiting MDM2 and in turn up-regulating p53 levels [10] . LRF over-expression keeps p19ARF level down,preventing the onset of the senescence program and allowing single oncogenic proteins such as Ras to transform MEF [9] .
Although it has been shown that LRF is over-expressed in some human cancers [8] , little is known about the mechanisms causing its up-regulation.
MicroRNAs (miRNAs) have recently come into focus as a novel class of post-transcriptional regulatory elements. They are abundant endogenous ,22-nucleotides (nt) RNAs that repress mRNA translation by base pairing to 39UTR sequences [11] . The miRNA-target recognition is mainly due to the perfect complementarity between a short 7-8 nt stretch at 59 end of the miRNA molecule (miRNA seed) and the corresponding stretch on the 39UTR of the target gene (seed match). This results in a reduced translation and in turn a decreased level of the protein [12] .
Some of the most studied microRNAs involved in human cancer are those belonging to miR-17-92 cluster. This cluster is located in a region amplified in lymphoma [13, 14] and lung cancers [15] while in other types of cancer, including nasopha-ryngeal carcinoma [16, 17] , hepatocellular carcinoma [18] and breast cancer [19] , the genomic location of the miR-17-92 cluster undergoes loss of heterozygosity suggesting that it may behave both as oncogene and oncosuppressor.
Enforced expression of the miR-17-92 cluster along with c-Myc expression accelerates tumor development in a mouse B-cell lymphoma model [13] . The underlying mechanism of action appears to be the E2F1 down-regulation by two members of the cluster, miR-17 and miR-20a. This c-Myc/miR-17-92 circuit helps to maintain E2F1 protein level below a pro-apoptotic threshold and cell proliferation prevails [20, 21, 22, 23] .
On the other hand, in breast cancer cells the most relevant target of miR-17 is not E2F1, but AIB1. The nuclear receptor coactivator, amplified in breast cancer 1 (AIB1), acts as an oncogene. It actually enhances the transcriptional activity of many transcription factors, among which the estrogen receptor. Indeed, when miR-17 is overexpressed in breast cancer cells, a big decrease in ER-mediated signaling and in turn proliferation is observed and cells loose their ability to form colonies in soft agar [24] .
Here, we report a novel activity exerted by miR-20a in mouse embryonic fibroblasts (MEF). This microRNA is able to control LRF protein at the post-transcriptional level and, when overexpressed, it induces premature senescence. This effect appears to be due to p19ARF up-regulation accompanied by up-regulation of p16 and down-regulation of E2F1.
Results
We utilized early passages MEF, known to express LRF [9] , to investigate whether this anti-senescence gene is regulated by miRNAs.
miR-20a regulates LRF protein at the post-transcriptional level
In silico analysis with TargetScanS (http://genes.mit.edu/ targetscan/) indicated various miRNA families potentially targeting the mouse zbtb7a 39UTR. We focused our attention on the miR-17 family whose members are reported in Figure 1a [25] . Before testing if mouse zbtb7a 39UTR interacts with miR-17 family members, the expression of representative members of the family was ascertained by RT-PCR. As reported in Figure 1b , MEF express the precursor of miR-20a, miR-17 and miR-106b, while they do not express the precursor of miR-106a. We then tested whether mouse zbtb7a 39UTR interacts with miR-20a, miR-17 and miR-106b, using an EGFP reporter assay. miRNA-expressing plasmids (p-miRs) were investigated for their ability to inhibit fluorescence and it was found that p-miR-20a (Figure 1d ), p-miR-17 ( Figure 1e ) and p-miR-106b (Figure 1f ) all inhibit in a dose dependent manner.
Since we decided to focus on miR-20a throughout the experiments, the presence of the mature form in MEF cells was first ascertained by Northern blot (Figure 1c) . To demonstrate the direct interaction, we again used the EGFP reporter assay. p-miR20a was tested against p-zbtb7a 39UTR wild type or mutated at the two binding sites specific for miR-17 family. p-miR-20a/ p-zbtb7a 39UTR interaction reduced the fluorescence, while p-miR-20a/p-zbtb7a 39UTR m interaction rescues the inhibition (Figure 1g ) indicating that miR-20a binds directly zbtb7a 39UTR.
Gain and loss of functions experiments were then performed. We observed that miR-20a over-expression, by transfection of 80 nM mature miR-20a, reduces LRF protein by 40% (Figure 1h ). Conversely, inhibition of endogenous miR-20a by transfection with 80 nM antisense 29-O-methyl-oligoribonucleotide (decoy, d20a) increases LRF protein level by 55% (Figure 1i ).
miR-20a over-expression induces p19ARF
LRF has been shown to be a specific transcriptional repressor of p19ARF [9] . The transient over-expression of miR-20a shows that 48 hours post transfection the level of LRF mRNA was almost unchanged, while it was reduced following a si-RNA specific for LRF, si-LRF, (Figure 2a ). p19ARF was more strongly upregulated by si-LRF than by miR-20a at both the mRNA (Figure 2a ) and protein (Figure 2b ,c) levels in agreement with the degree of LRF inhibition. Downstream of p19ARF, p53 expression level was slightly increased while p21 level remained similar to control cells (Figure 2b,c) .
miR-20a over-expression decreases cell proliferation and induces senescence
The p19ARF up-regulation is known to inhibit MEF proliferation and to trigger senescence [9] . For this reason we investigated the effect of miR-20a on these two biological end points in MEF at early passages. MEF transfected with miR-20a proliferated less than those transfected with control miRNA (Figure 3a) . To evaluate senescence, the number of SA-b-gal positive and binucleated cells was determined 96 hours post transfection. miR-20a significantly enhanced SA-b-gal positive ( Figure 3b ) and binucleated ( Figure 3c ) cells over control level. It can be noted that si-LRF was less efficient than miR-20a despite the stronger induction of p19ARF.
To reinforce the finding that miR-20a induced senescence, LRF positive and null-LRF MEF were infected with a retrovirus expressing miR-20a (PIG/miR-20a) in order to achieve a stable expression. The results show that PIG/miR-20a markedly inhibits cell proliferation (Figure 3d (Figure 4c ). [20, 21] We therefore asked whether E2F1 down-regulation per se contributed to senescence. MEF were transfected with si-E2F1: the expression of E2F1 was reduced but the reduction was not accompained by p19ARF upregulation (Figure 4d ). In agreement with this result senescent cells were not induced (Figure 4e ) demonstrating that E2F1 down-regulation is not enough per se to induce senescence.
We asked whether another key senescence inducer, the tumor suppressor p16, might be induced by miR-20a overexpression. We found that only miR-20a and not si-LRF is able to increase p16 protein levels ( Figure 5 a,b) . Moreover, transient miR-20a transfection in LRF-null MEF demonstrates that miR-20a is able to induce p16 also in the absence of LRF (Figure 5c ). RT-PCR analysis of pri-miRNA expression in MEF. Total RNA was extracted and amplified by RT-PCR using appropriate primers. The PCR products of ,500 bp length are pri-miRNAs of the miR-17 family; c: Northern blot analysis of mature miR-20a expression in MEF. 20 mg of total RNA was analyzed with miR-20a probe or valine tRNA control probe; d, e, f: Interaction between 39UTR of mmu-zbtb7a mRNA and miR-17 family. HEK293T cells were co-transfected with p-zbtb7a 39UTR and increasing concentrations of p-miR-20a, p-miR-17 p-miR-106b or p-miR-26a control plasmid. 24 hours after transfection, cells were collected and the EGFP fluorescence intensity of each sample was determined with a FACscan analyzer. The relative expression of p-zbtb7a 39UTR was obtained by the ratio of the mean fluorescence value of HEK293T cells transfected with p-miR-20a, p-miR-17 or p-miR-106b and the mean fluorescence value of HEK293T cells transfected with p-miR-26a control plasmid. Each bar represents the mean6SE of three independent experiments; g,: Transfection of p-miR-20a with either p-zbtb7a 39UTR or p-zbtb7a 39UTR m in HEK293T. Cells were collected 24 hours after transfection and the EGFP fluorescence intensity of each sample was determined with a FACscan analyzer. The relative expression was obtained by the ratio of the mean fluorescence values of HEK293T cells cotransfected with p-miR-20a and either p-zbtb7a 39UTR or p-zbtb7a 39UTR m normalized to that of HEK293T cells transfected with pEGFPC1. Each bar represents the mean6SE of three independent experiments. h i: Effects of overexpression/depletion of miR-20a on LRF expression. doi:10.1371/journal.pone.0002542.g001
Discussion
The persistent mitogenic stimulation during the propagation in culture induces senescence in MEF [26] . Senescence is also induced by cellular stresses such as the over-expression of single oncogenes [27] , free radicals [28] , or DNA damaging drugs [29] . While the culture induced senescence occurs after 5-6 passages in culture, the stress-induced senescence appears 48-72 hours after the insult. The induction of both types of senescence is mediated by the transcriptional activation of the INK4a locus and the consequent increase of the two encoded proteins p19ARF and p16INK4a [30, 31] ; p19ARF protein up-regulates p53 levels by inhibiting MDM2 [10] while p16INK4a inhibits cyclin dependent kinases thereby activating the retinoblastoma protein [32] . Moreover p19ARF has been reported to associate with proteins other than MDM2 and to have p53-independent activities most of which remain to be elucidated [30] .
The transcriptional repressor LRF prevents the senescence program in MEF by inhibiting p19ARF transcription [9] . From an in silico analysis we found that zbtb7a 39UTR is predicted to be the target of several miRNA families, among which is miR-17 family (Figure 1a) . Using a hybrid reporter assay, we were able to demonstrate that miR-17 family members, in particular miR-20a, interact directly with zbtb7a 39UTR (Figure 1d ,e,f,g). We also overexpressed miR-20a in MEF and found that LRF protein was consistently decreased (Figure 1h) , while the mRNA level was unchanged (Figure 2a) . Viceversa the depletion of the endogenous miR-20a by the antisense d-20a increased LRF protein level (Figure 1i) . These results clearly demonstrate that in MEF LRF is under miR-20a control.
Interestingly, we observed that the transient and stable miR-20a over-espression direct MEF toward senescence (Figure 3b,e) , more similar to stress rather than to culture induced senescence, as it is accomplished within few days from transfection.
It is well known that miRNAs modulate the expression of several targets at once and in this way they activate or inhibit pathways [33, 34] . The final output depends on the fine-tuning of different players of the pathways. The miR-20a-induced senescence in MEF is not an exception to this rule. The results obtained following the stable and transient expression of miR-20a indicate the important role of LRF down-regulation/p19ARF up-regulation, but also suggest that other targets are involved. This assumption is based on the finding that miR-20a is a more powerful senescence inducer than si-LRF, although it is a milder inhibitor of LRF/inducer of p19ARF (Figure 2c ) and that in LRFnull MEF additional senescence is induced (figure 3e).
Looking for other possible miR-20a targets, we focused our attention on E2F1, already known to be under miR-17 family control [20, 21, 23] . We confirmed that, when miR-20a is overexpressed either by transient transfection (Figure 4a ) or stable infection (Figure 4b ), E2F1 is invariably decreased. Furthermore, when endogenous miR-20a is depleted by decoy, E2F1 protein level is slightly increased confirming that E2F1 is under miR-20a control in MEF (Figure 4c) .
The role of E2F1 in senescence is controversial. p19ARF is under the transcriptional control of E2F1 [35] and this explains how premature senescence can be induced by oncogenic stresses, among which E2F1 over-expression [36] . Nonetheless, in an E2F1-null setting, proper stimuli can still induce p19ARF and senescence [10] . Moreover, p19ARF can in turn decrease E2F1 protein level/activity [37, 38, 39] . Also, in some cellular context the down-regulation of E2F1 is a necessary prerequisite for senescence [40, 41] . In agreement with an anti-senescence role of E2F1, we found that si-LRF transfection slightly increases MEF senescence and induces a decrease of E2F1 (Figure 4d ), possibly p19ARF-dependent. On the other hand miR-20a was able to induce a more profound E2F1 down-regulation than si-LRF both in wt and in LRF-null cells (Figure 4a,b) , possibly by direct binding of this microRNA to the 39UTR of E2F1 mRNA. These data strongly suggest that miR-20a induced premature senescence is due to the cooperation of LRF and E2F1 down-regulation. This hypothesis is supported by the finding that E2F1 knock-down by si-E2F1 per se is not enough to induce senescence (Figure 4e ) and by the significant increase of senescence in LRF-null MEF over-expressing miR-20a concomitant with E2F1 reduction (Figure 3e ). We also found that miR-20a increases another important senescence player, p16 [42] , in both wild type (Figure 5a,b) and LRF-null MEF (Figure 5c ). Recently the p16 pathway has been shown to have a central role in induction of premature senescence establishing an autonomous activation of ROS production via inhibition of E2F1 activity [28] . This circuit leads at the end to a cytokinesis block due to PKC activation [28] and a inhibition of mitotic exit network kinase, WARTS [43, 44] . Although we have not investigated these activities, the significant induction of binucleated cells by miR20a (Figure 3c ) and the decrease in E2F1 level are consistent with the activation of the p16 pathway as well. LRF down-regulation does not seem to play a role in p16 induction, because it has been previously reported to specifically inhibit p19ARF, but not p16 transcription [9] . We observed that, as opposed to miR-20a, si-LRF causes only p19ARF (Figure 2c ) and not p16 (Figure 5a ) upregulation. Furthermore, p16 is induced by miR-20a in both wt (Figure 5a ) and LRF-null MEF (Figure 5c) . A plausible hypothesis miR-20a-Induced Senescence is that miR-20a directly or indirectly affects a negative regulator of p16. In this respect, it is of note that E2F1 and c-Myc are linked by a positive feedback loop [45, 46] , so that miR-20a-induced E2F1 down-regulation might decrease c-Myc level. Reduced c-Myc level has been shown to trigger senescence by inducing p16 via Bmi-1 down-regulation [47] . In our case the concomitant downregulation of E2F1 accompanied by p16 up-regulation are events which cooperate with LRF down-regulation to induce senescence. The combined modulation of these different proteins is likely to be at the basis of the senescence pathways elicited by miR-20a-overexpression.
In conclusion our data demonstrate that in MEF at early passages miR-20a is able to induce cellular senescence. The direct downregulation of LRF, with the consequent induction of p19ARF, is a key mediator of the process, but the cooperation with other pathways, represented by E2F1 down-regulation and p16 upregulation, appears to contribute. The finding that miR-20a is able to induce premature senescence is, in our opinion, interesting as it may have potential clinical relevance as anti-tumorigenic drug. 
Materials and Methods

Reagents
Cells and culture conditions
Wt and LRF-null mouse embryonic fibroblasts (MEF) were isolated from 13.5d mouse embryos. Briefly, embryos were mechanically fragmented and then incubated with trypsin (0.25% in PBS pH 7.5) at 37uC for 15-20 minutes with a magnetic stirrer. After 10 minutes centrifugation at 2906g, pellets were resuspended in Dulbecco's Modified Eagle Medium+High Glucose (DMEM-HG) without fetal bovine serum (FBS) and centrifuged for 10 minutes at 2906g. After three washings, the cell suspension was distributed in culture dish containing complete DMEM-HG+10% FBS. Cells were trypsinized at confluency (p1). The propagation protocol 3T6 (6610 5 cells/100 mm diameter dish transferred every 3 days) was followed. HEK 293T and Phoenix E cells were grown in DMEM+10% FBS. All cells were grown at 37uC in a humidified atmosphere containing 6% CO 2 .
Plasmids
The entire mmu-zbtb7a 39UTR (Acc Nu NM_010731) was obtained by PCR from genomic DNA. F (59-GAG AAG CAC TTT AAG GAC GAG-39) and R (59-GAT AGG AAG GCA AAG AGC A -39) primers were used (T a 57uC). The fragment was cloned downstream of EGFP ORF within pEGFP-C1 plasmid and a stop codon was inserted between the EGFP and the target fragment, so that the transcribed mRNA is a hybrid molecule but the translated protein is EGFP. The plasmid p-zbtb7a 39UTR was constructed. The mutated version of this plasmid (p-zbtb7a 39UTR m ) was generated by utilizing the p-zbtb7a 39UTR as template and modifying the miR-20a seed binding site using the QuikChange II XL Site-Directed Mutagenesis Kit. The mutagenic primers used were: site1 (position 2764 mRNA zbtb7a) forward 59-TCCCC-ACTTTTTAAGT*T*AG*TTTTTAGATCG-39 and reverse 59-GCATCTAAAAAC*TA*A*CTTAAAAAGTGGGGA-39; site2 (position 3061 mRNA Zbtb7a) forward 59-GTGGGGATCTTGG-CAT*A*TG*GTAACTGAACGG-39 and reverse 59-CCGTT-CAG TTAC C*AT*A*TGCCAAGATCCCCAC-39, where the asterisks indicate the mutated bases.
Genomic fragments of about 500 bp which contained human pri-miR-17, pri-miR-20a, pri-miR-106a, pri-miR-106b or primiR-26a sequences were obtained by PCR. Primers were: F (59-TTTGGAACTTCTGGCTATTG-39) and R (59-GGCTGCAA-ACACAACTA-39) for pri-miR-17; F (59-AGTCGTCGGT-CAGTCG-39) and R (59-CAAACCTGCAAAACTAACCATA-39) for pri-miR-20a; F (59-TGAGATTGCCAGTGTTATTC-39) and R (59-TAAGAAGTAGCCTGTGCG-39) for pri-miR-106a; F (59-GCAGCATATGTGGAGATG-39) and R (59-TCAGCAG-TAGGTACGGTAA-39) for pri-miR-106b; F (59-CCACTGCT-GACCCATTCT-39) and R (59-AAGACTCCTCGTTGCCAG-39) for pri-miR-26a. Annealing temperatures were: 54.9uC for primiR-17, 54.2uC for pri-miR-20a, 57.6uC for pri-miR-106b, and 57uC for pri-miR-26a. F primers were elongated at the 59 ends to include the GGATCC sequence and R primers were elongated at 59 ends to include the CTCGAG sequence to create BamHI and XhoI restriction sites, respectively. The PCR products were cloned downstream of the CMV promoter within the pCMV-MCS plasmid. In this way, the expression plasmids nick-named p-miR20a, p-miR-17, p-miR-106b and p-miR-26a were obtained.
pri-miR20a was amplified by PCR from genomic human DNA using the following primers: F 59-TATTTCCTTCAAATGAAT-GAT-39 and R 59-TTCAGTAACAGGACAGTTTGA-39. The sequence was then subcloned into MSCV-PIG [9] using BglII and XhoI (PIG/miR-20a).
RT-PCR
To detect the expression of pre-miRNAs, total RNA was extracted from MEF using the RNeasy mini kit. After DNase treatment, 1 mg RNA was retrotranscribed using SuperScript II reverse transcriptase. The primers were those used for cloning. 2 ml of the RT mixture was then added in 50 ml PCR reactions and 7 ml aliquots were loaded on gel.
Northern blot 20 mg of total RNA, extracted using the Trizol reagent, were loaded onto a 15% polyacrylamide 7 M urea gel, electrophoresed and successively electroblotted onto Hybond N + membrane. The oligonucleotide used as probe was the complementary sequence of the mature miR-20a (miRNA Registry): (59-CTACCTGCACTA-TAAGCACTTTA-39). Probes were end-labelled with [c-32 P]ATP (300 Ci/mmole) by T4 polynucleotide kinase. Prehybridization and hybridization were carried out in Ultrahyb Oligo solution containing 25 mg salmon sperm DNA and 10 6 cpm/ml labelled probes at 37uC overnight. Washing was performed in 66SSPE at 37uC. As a loading control, membranes were stripped and rehybridized with valine tRNA probe (59-GAACGTGATAAC- 
MEF transfection
Exponentially growing MEF at passage 2 were transfected with miR-20a, d-20a, siRNA-LRF, a siRNA specific for LRF (59-CAUAAAGAAGAGUGGGAAG-39) or si-E2F1 (Dharmacon). Briefly, 15 ml Optimem and 25 ml transfection buffer plus 80 nM miRNA or d-20a were mixed with a solution of Gene Silencer (5 ml) plus Optimem (25 ml). After 15 minutes incubation, Optimem was added up to 800 ml. Then, the transfection mixture was added to 1.2610 6 cells resuspended in 200 ml Optimem. After 5 min, 10 ml Optimem was added and the suspension distributed in culture dishes at a density of 2610 4 cells/cm 2 . After 6 hours the medium was replaced with complete DMEM-HG. With this protocol more than 90% of MEF were transfected (data not shown). Cells were collected at specified time points after transfection and further analyzed.
MEF retroviral infection
For retrovirus-mediated gene transfer, Phoenix E cells (3610   6   ) were plated in a 100 mm poly-D-Lysine coated dish and, 16 hours later, were transfected with retroviral plasmid (PIG/miR-20a) using Lipofectamine 2000. 48 hours later, the virus-containing medium (10 ml) was filtered, mixed with 5 ml of freshly prepared medium and supplemented with 4 mg / ml polybrene. 7610 5 MEFs at passage 2 were plated in a 100 mm dish. 16 hours later, the medium was replaced with viral supernatant. Puromycin (2 mg /ml) was administered 48 hours after infection. The cells were subsequently selected for 2 days and then utilized for the various assays.
Western blot
Transfected cells grown for 48 hours in 100 mm diameter dishes were collected, centrifuged and lysed (20 mM Tris-HCl pH 8.0; 20 mM NaCl; 10% glycerol; 1% NP40; 10 mM EDTA; 2 mM PMSF, 2.5 mg/ml leupeptin). Infected cells were collected immediately at the end of antibiotic selection. Proteins (30 mg/ lane) were separated on 12% SDS-polyacrylamide gel and transferred to nitrocellulose membrane.
Immunoblotting of the membranes was performed using the following primary antibodies: anti-LRF (1:1000); anti-E2F1 (1:1000); anti-p16 (1:250); anti-p21 (1:1000); anti-p19ARF (1:1000); anti-p53 (1:1000); anti-a-tubulin (1:20000); anti-GAPDH (1:10000). Signals were revealed after incubation with recommended secondary antibody coupled to peroxidase by using enhanced chemiluminescence. Scanned images were quantified using Scion Image software.
Real-time PCR analysis
To evaluate mouse p19ARF, p21, and zbtb7a mRNA levels, total RNA was extracted from transfected MEF using Trizol reagent according to the manufacturer's instructions. DNase treatment and retrotranscription were performed as described above. Realtime PCR was carried out using ABI PRISM 7700 Sequence Detection System (Applied Biosystems) and LightCycler 480 (Roche). Taqman probes and oligonucleotides used were as follows: for p19ARF, F (59-CATGGGTCGCAGGTTCTTG-39), R (59-GCTCGCTGTCCTGGGTCTC-39) and probe (59-CACTGT-GAGGATTCAGCGCGCG-39); for LRF, F (59-AACTACGACC-TGAAGAACCACATG-39), R (59-AGATGGTCGGAGCGCA-CA-39) and probe (59-CTGCGGCCATACCAGTG CGATAGC-39); for p21, F (59-TCCACAGCGATATCCAG ACA-39), R (59-GGACATCACCAGGATTGGAC-39) and LNA probe (59-GG-CCCTGG-39). Relative quantitation of gene expression was performed with the comparative C T method. GAPDH was amplified with the following primers: F (59-GCCTTCCGTG-TTCCTACCC-39), R (59-TGCCTGCTT CACCACCTTC-39) and probe (59-CCTGGAGAAACCTGCCAAGTATGATGA-CATC-39) and used as internal standard. Mature miR-20a was quantified using the miScript System according to the manifacturer's instruction. Oligonucleotides 59-TAAAGTGCTTATAGTGCAG-GTAG-39 and 59-CGCAAGGATGACACGCAAATTC-39 were used as forward primers respectively of miR-20a and U6 in the real time amplification mixtures. All reactions were performed in triplicate Cellular read outs.
Cell proliferation
48 hours post-transfection, 1610 5 cells were seeded in a series of 30 mm diameter dish and grown for 96 hours. At 24 hours intervals cells were collected and counted. Growth curves after infection were generated by seeding 2.5 10 4 cells per 12 well plates in triplicate for three independent experiments. Cells were subsequently fixed in paraformaldeyde at defined time points and subsequently stained with cristal violet. After lysis with acetic acid 10%, O.D. is read at 590 nm.
Senescence-associated (SA) b-galactosidase activity 48 hours post-transfection, 4610 4 cells were seeded in 30 mm diameter dish and 48 hours later dishes were washed once with PBS and fixed for 3-5 minutes at room temperature in PBS containing 2% formaldehyde/0.2% glutaraldehyde. Cells were then washed three times in PBS, and incubated at 37uC with fresh SA-b-gal staining solution containing 1 mg/ml 5-bromo-4-chloro-3-indolyl P3-D-galactoside (X-Gal) (stock = 20 mg/ml in DMSO), 5 mM potassium ferrocyanide, 5 mM potassium ferricyanide, 2 mM MgCl 2 in PBS pH6.0. SA-b-gal positive cells were scored after 48 hours by counting 500 cells with normal light microscopy. For infection experiments, cells were plated as described above (Cell Proliferation) and were scored 5 days after plating.
Binucleated cells
48 hours post-transfection, 4610 4 cells were seeded in 30 mm dish and 48 hours later dishes were washed with PBS and fixed for 10 minutes with formaldehyde at room temperature. Cells were then stained with 0.1% crystal violet/20% methanol for 15 min. Binucleated cells were scored counting 500 cells by normal light microscopy.
Statistical analysis
Data were analyzed using GraphPad prism (GraphPad Software, Inc., San Diego, CA). Statistical differences were determined by unpaired t-test, with values of P,0.05 considered statistically significant.
